In Vitro Susceptibility of Mycobacterium ulcerans Isolates to Selected Antimicrobials

Table 1

Minimum inhibitory concentration (g/mL) of the antimicrobials.

Antimicrobials	MIC of M. ulcerans isolates (in g/mL)
	GH	BN	A5	A9	A13	A61	A68	A69	N1	N2	N5	N8
Az	0.16	0.63	0.63	0.16	0.16	0.31	0.31	0.16	0.63	0.63	0.31	0.63
Rif	1.25	0.63	0.63	0.16	0.16	1.25	0.63	0.63	1.25	0.63	1.25	1.25
Dap	0.31	0.63	1.25	1.25	0.63	1.25	1.25	0.63	0.31	1.25	1.25	1.25
Str	0.63	1.25	0.63	1.25	1.25	1.25	1.25	1.25	1.25	0.63	1.25	1.25
Amk	0.63	1.25	0.63	2.50	1.25	2.50	2.5	1.25	0.63	1.25	0.63	1.25
Cip	1.25	1.25	1.25	1.25	0.63	1.25	1.25	0.63	1.25	1.25	1.25	1.25
Ofl	1.25	0.63	1.25	1.25	0.63	1.25	2.50	2.50	1.25	2.5	1.25	2.50
Clo	2.50	2.50	2.50	1.25	1.25	1.25	2.50	2.50	2.50	2.50	2.50	2.50

BN: Benin, GH: Ghana, A: Amasaman, N: Nsawam, Az: azithromycin, Rif: rifampicin, Dap: dapsone, Str: streptomycin, Amk: amikacin, Cip: ciprofloxacin, Ofl: ofloxacin, and Clo: clofazimine. GH and BN are lab strains.